Synthetic Biology

King's College London, bit.bio collaboration launched to build multicell brain models

By Matt Limb

A collaboration has been launched in the U.K. to build multicell models of the human brain deemed vital to develop novel therapies for neuronal and psychiatric disorders.

December 5, 2023

Bit.bio unveils cell therapy candidate for liver conditions

By Matt Limb

Synthetic biology company bit.bio has unveiled a lead cell therapy candidate as a treatment for life-threatening liver conditions, and it has set out its broader cell therapy pipeline.

November 22, 2023

Bio-Techne to acquire Namocell

By LabPulse.com staff writers

Namocell's instrument portfolio includes Pala, a two-laser system with up to 11 fluorescent detection channels, and Hana, a single-laser system with two fluorescent detection channels.

June 21, 2022

Sherlock gets $5M to advance COVID-19 self-test platform

By LabPulse.com staff writers

The Bill & Melinda Gates Foundation provided the grant for the instrument-free, synthetic biology-based molecular diagnostic platform that can be used at home and at room temperature. The platform can be adapted to work on a simple paper strip test or to provide an electrochemical readout that can be read with a mobile phone.

December 15, 2020

Agilent christens new R&D center in Singapore

By LabPulse.com staff writers

The NUS-Agilent Hub for Translation & Capture aims to boost clinical diagnostics through biochemical innovation and research data analytics at laboratories based at the university and hospital. Scientists, clinicians, and industry partners will have 1,000 sq m of research space to collaborate and translate biochemical research into clinical applications.

August 19, 2019